Goodo.
But really all a tad vague, it seems to me: no indication of timing, no detail of milestones or of the relationship with St. Vincent’s Institute of Medical Research (which to be fair is likely as solid a partner EchoIQ could wish for).
Still counting down - now 76 sleeps - to 5 August for news from the US Food and Drug Administration (FDA) on EchoSolv™ AS.
Ann: Echo IQ Commences New Heart Failure Clinical Study Using AI, page-2
Add EIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
15.0¢ |
Change
-0.015(9.09%) |
Mkt cap ! $80.64M | |||
| Open | High | Low | Value | Volume |
| 15.5¢ | 15.5¢ | 15.0¢ | $80.70K | 536.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 99996 | 15.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.0¢ | 250544 | 5 |
View Market Depth
| Last trade - 16.10pm 29/07/2024 (20 minute delay) ? |
| EIQ (ASX) Chart |